Moreover, the detection of mammary gland-specific breast cancer marker Mammaglobin A in local wound tissue after bilateral mastectomy in all tested breast cancer patients (no tumor diagnosis yet) strengthens our data integrity immensely and confirms the high specificity but applicability of our approach. The gene discussed is SCGB2A2; the disease is breast carcinoma.